Bioequivalence of Two Formulations of Ondansetron in Healthy Adults (0869-106)

Clinical trial NCT00972595 · COMPLETED

Trial details

NCT number: NCT00972595
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chemotherapy-Induced Nausea and Vomiting

Start date: 2004-06-01
Primary completion: 2004-08-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.